PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW128624View Pathway |
drug action
Sibutramine Dopamine Reuptake Inhibitor Action PathwayHomo sapiens
Sibutramine, commonly known as Meridia or Reductil, is a norepinephrine, serotonin and dopamine reuptake inhibitor used for the treatment of obesity. This drug was withdrawn from US and Canadian markets for increased risk of heart attack and stroke in patients with heart disease history. Sibutramine stimulates the nervous system through the reuptake of norepinephrine, serotonin and dopamine, which prolongs their duration in the synapse so that they can bind more readily to the receptors. The mechanism is not fully understood, but may be similar to other dopamine reuptake inhibitors where Sibutramine would cross the blood-brain barrier through diffusion. Dopamine is synthesized in the ventral tegmental area of the brain from tyrosine being synthesized into L-dopa by the enzyme Tyrosine 3-monooxygenase . L-Dopa is then synthesized into dopamine with the enzyme aromatic-L-amino-acid decarboxylase. Dopamine then travels to the prefrontal cortex, which is released into the synapse when the neuron is stimulated and fires. Sibutramine binds to the sodium-dependent dopamine transporter, preventing dopamine from re-entering the presynaptic neuron. The dopamine then binds to Dopamine D4 receptors on the postsynaptic membrane. The dopamine D4 receptor activates the Gi protein cascade, which inhibits adenylate cyclase. This prevents adenylate cyclase from catalyzing ATP into cAMP.
|
Creator: Ashley Zubkowski Created On: September 06, 2023 at 17:45 Last Updated: September 06, 2023 at 17:45 |
PW145194View Pathway |
drug action
Sibutramine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:16 Last Updated: October 07, 2023 at 15:16 |
PW176231View Pathway |
Sibutramine Predicted Metabolism PathwayHomo sapiens
Metabolites of Sibutramine are predicted with biotransformer.
|
Creator: Omolola Created On: December 04, 2023 at 12:59 Last Updated: December 04, 2023 at 12:59 |
PW064707View Pathway |
signaling
Sigma B ActivationBacteria
|
Creator: Guest: Anonymous Created On: March 29, 2018 at 01:42 Last Updated: March 29, 2018 at 01:42 |
PW146361View Pathway |
drug action
Silanol Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:01 Last Updated: October 07, 2023 at 18:01 |
PW126170View Pathway |
drug action
Sildenafil Action PathwayHomo sapiens
Sildenafil is a phosphodiesterase-5 inhibitor used for the treatment of erectile dysfunction.
Sexual stimulation causes the release of nitric oxide (NO) from nerves and endothelial cells into the penis. NO activates the enzyme guanylate cyclase.2 The activation of this enzyme is followed by the synthesis of cyclic guanosine 3',5'-monophosphate (cGMP), activating a cascade of protein kinase-dependent phosphorylation events in smooth muscles, ultimately resulting in the dephosphorylation of myosin light chains within smooth muscle. This activity causes the relaxation of smooth muscle within blood vessels, resulting in the desired vasodilatory effect. Phosphodiesterase-5 breaks down cGMP to GMP. Sildenafil inhibits phosphodiesterase-5, preventing the breakdown of cGMP. This increases the concentration of cGMP, increasing the vasodilation and improving blood flow leading to penile erection.
|
Creator: Karxena Harford Created On: July 28, 2021 at 23:48 Last Updated: July 28, 2021 at 23:48 |
PW144334View Pathway |
drug action
Sildenafil Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 13:25 Last Updated: October 07, 2023 at 13:25 |
PW175936View Pathway |
Sildenafil Predicted Metabolism PathwayHomo sapiens
Sildenafil PIS1M1, Sildenafil PIS1M2, Sildenafil PIS2M1 are metabolites of Sildenafil predicted with biotransformer.
|
Creator: Omolola Created On: November 16, 2023 at 12:44 Last Updated: November 16, 2023 at 12:44 |
PW146253View Pathway |
drug action
Silicon dioxide Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:47 Last Updated: October 07, 2023 at 17:47 |
PW146576View Pathway |
drug action
Silicon Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:33 Last Updated: October 07, 2023 at 18:33 |